Transwell® assays confirmed that LINC01016 overexpression enhanced the migration and invasion of BC cells, whereas silencing its expression suppressed both of these activities (Fig. 3G, H; Supplementary Fig. 1E; Supplementary Fig. 3D). Here, LINC01016 is linked to breast cancer.